Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Connectivity map-based drug repositioning of bortezomib to reverse the metastatic effect of GALNT14 in lung cancer
Ok-Seon Kwon, Haeseung Lee, Hyeon-Joon Kong, et al.
Oncogene (2020) Vol. 39, Iss. 23, pp. 4567-4580
Open Access | Times Cited: 32

Showing 1-25 of 32 citing articles:

Computational drug repurposing by exploiting large-scale gene expression data: Strategy, methods and applications
Hao He, Hongrui Duo, Youjin Hao, et al.
Computers in Biology and Medicine (2023) Vol. 155, pp. 106671-106671
Closed Access | Times Cited: 23
Lycorine improves peripheral nerve function by promoting Schwann cell autophagy via AMPK pathway activation and MMP9 downregulation in diabetic peripheral neuropathy
Qingqing Yuan, Xiang Zhang, Wandi Wei, et al.
Pharmacological Research (2021) Vol. 175, pp. 105985-105985
Closed Access | Times Cited: 42
5-aminosalicylic acid suppresses osteoarthritis through the OSCAR-PPARγ axis
Jihee Kim, Gina Ryu, J. G. Seo, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 8
LPCAT1 overexpression promotes the progression of hepatocellular carcinoma
Rong‐Quan He, Jian‐Di Li, Xiu‐Fang Du, et al.
Cancer Cell International (2021) Vol. 21, Iss. 1
Open Access | Times Cited: 35
Drug Repurposing for Cancer Therapy in the Era of Precision Medicine
Kenneth K.W. To, William C. Cho
Current Molecular Pharmacology (2022) Vol. 15, Iss. 7, pp. 895-903
Closed Access | Times Cited: 26
Discovery of drug targets and therapeutic agents based on drug repositioning to treat lung adenocarcinoma
Occam Kelly Graves, Woonghee Kim, Mehmet Özcan, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 161, pp. 114486-114486
Open Access | Times Cited: 11
Systematic omics analysis identifies CCR6 as a therapeutic target to overcome cancer resistance to EGFR inhibitors
Eunji Kwon, Hyuk‐Jin Cha, Haeseung Lee
iScience (2024) Vol. 27, Iss. 4, pp. 109448-109448
Open Access | Times Cited: 4
Mechanism of the GALNT family proteins in regulating tumorigenesis and development of lung cancer (Review)
Changhong Miao, Ronggui Sun, D. Ji, et al.
Molecular and Clinical Oncology (2025) Vol. 22, Iss. 4, pp. 1-9
Open Access
Crosstalk between YAP and TGFβ regulates SERPINE1 expression in mesenchymal lung cancer cells
Hyeon‐Joon Kong, Eunji Kwon, Ok‐Seon Kwon, et al.
International Journal of Oncology (2020) Vol. 58, Iss. 1, pp. 111-121
Open Access | Times Cited: 32
Identification of a novel anticancer mechanism of Paeoniae Radix extracts based on systematic transcriptome analysis
Su‐Jin Baek, Haeseung Lee, Sang‐Min Park, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 148, pp. 112748-112748
Open Access | Times Cited: 18
Integrated analysis of multiple programmed cell death-related prognostic genes and functional validation of apoptosis-related genes in osteosarcoma
Zhen Tang, Zhang Zhi, Jungang Zhao, et al.
International Journal of Biological Macromolecules (2025), pp. 142113-142113
Closed Access
Multiple isogenic GNE-myopathy modeling with mutation specific phenotypes from human pluripotent stem cells by base editors
Ju-Chan Park, Jumee Kim, Hyeon‐Ki Jang, et al.
Biomaterials (2022) Vol. 282, pp. 121419-121419
Closed Access | Times Cited: 16
Simple, fast, and flexible framework for matrix completion with infinite width neural networks
Adityanarayanan Radhakrishnan, Georgios Stefanakis, Mikhail Belkin, et al.
Proceedings of the National Academy of Sciences (2022) Vol. 119, Iss. 16
Open Access | Times Cited: 15
Epigenetic repression of CHCHD2 enhances survival from single cell dissociation through attenuated Rho A kinase activity
Jumee Kim, Eunji Kwon, Yun-Jeong Kim, et al.
Cellular and Molecular Life Sciences (2024) Vol. 81, Iss. 1
Open Access | Times Cited: 3
Incorporating machine learning and PPI networks to identify mitochondrial fission-related immune markers in abdominal aortic aneurysms
Yi-jiang Liu, Rui Li, Di Xiao, et al.
Heliyon (2024) Vol. 10, Iss. 7, pp. e27989-e27989
Open Access | Times Cited: 2
Unlocking the potential of signature-based drug repurposing for anticancer drug discovery
Sruti Biswal, Bibekanand Mallick
Archives of Biochemistry and Biophysics (2024) Vol. 761, pp. 110150-110150
Closed Access | Times Cited: 2
Systematic transcriptome analysis reveals molecular mechanisms and indications of bupleuri radix
Sang‐Min Park, Aeyung Kim, Haeseung Lee, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 11
Drug Repurposing to Treat Glucocorticoid Resistance in Asthma
Alberta L. Wang, Ronald Allan M. Panganiban, Weiliang Qiu, et al.
Journal of Personalized Medicine (2021) Vol. 11, Iss. 3, pp. 175-175
Open Access | Times Cited: 12
In silico approaches for drug repurposing in oncology: a scoping review
Bruno Raphael Ribeiro Cavalcante, Raíza Dias Freitas, Leonardo de Oliveira Siquara da Rocha, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 1
TGFβ promotes YAP‐dependent AXL induction in mesenchymal‐type lung cancer cells
Jeong‐Yun Choi, Haeseung Lee, Eunji Kwon, et al.
Molecular Oncology (2020) Vol. 15, Iss. 2, pp. 679-696
Open Access | Times Cited: 11
Nanotopography as Artificial Microenvironment for Accurate Visualization of Metastasis Development via Simulation of ECM Dynamics
Chun-San Tai, Kuan-Chun Lan, Erick Wang, et al.
Nano Letters (2021) Vol. 21, Iss. 3, pp. 1400-1411
Closed Access | Times Cited: 10
Prognostic impact of caspase‐8 mutation in oral cavity squamous cell carcinoma
Hsueh‐Ju Lu, Chun‐Wen Su, Shih‐Chi Su, et al.
Oral Diseases (2024)
Closed Access | Times Cited: 1
O-Glycosylating Enzyme GALNT2 Predicts Worse Prognosis in Cervical Cancer
Lixia Zhou, Huiqin Wu, Xingli Bai, et al.
Pathology & Oncology Research (2022) Vol. 28
Open Access | Times Cited: 5
Deep Learning Approach Based on Transcriptome Profile for Data Driven Drug Discovery
Eunji Kwon, Hyuk‐Jin Cha
Molecules and Cells (2023) Vol. 46, Iss. 1, pp. 65-67
Open Access | Times Cited: 2
Luteolin Induces Selective Cell Death of Human Pluripotent Stem Cells
Young-Hyun Go, Jumee Kim, Ho‐Chang Jeong, et al.
Biomedicines (2020) Vol. 8, Iss. 11, pp. 453-453
Open Access | Times Cited: 4
Page 1 - Next Page

Scroll to top